HR 4764 · 116th Congress 2019–2021, ended

TRANSPLANT Act of 2020

Latest action · Dec 14, 2020 Message on Senate action sent to the House.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedOct 18, 2019
  2. Passed HouseSep 30, 2020
  3. Passed SenateDec 11, 2020
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020 or the TRANSPLANT Act of 2020

This bill modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also requires research and other activities related to stem cell therapies.

Specifically, the Department of Health and Human Services must conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments, and the National Institutes of Health must continue efforts to further the field of regenerative medicine using adult stem cells.

In addition, the Government Accountability Office must examine various issues related to the regenerative medicine workforce.

Recorded votes 1

Newest first. Open one to see how every member voted.

Roll callQuestionResultDate
House 211Passed414–0Sep 30, 2020

Cosponsors 52

Members who signed on, in the order they did. Signatures ran from Oct 18, 2019 to Sep 29, 2020; 2 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-MEChellie PingreeOriginalOct 18, 2019
R-FLGus M. BilirakisOriginalOct 18, 2019
R-PABrian K. FitzpatrickOct 22, 2019
D-TXSheila Jackson LeeOct 23, 2019
R-NCTed BuddOct 23, 2019
R-ORGreg WaldenOct 28, 2019
R-ALRobert B. AderholtOct 28, 2019
D-FLAlcee L. HastingsNov 12, 2019
D-CAEric SwalwellNov 12, 2019
D-COJoe NeguseNov 19, 2019
R-AKDon YoungNov 20, 2019
D-MDAnthony G. BrownDec 3, 2019
D-VTPeter WelchDec 3, 2019
D-CAHarley RoudaDec 4, 2019
D-NCG. K. ButterfieldDec 17, 2019

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Oct 18, 2019Markup Sep 9, 2020Reported Sep 29, 2020
Health Subcommittee
Referred Oct 21, 2019

Actions 18

Everything that happened, newest first.

  1. Dec 14, 2020Message on Senate action sent to the House.
  2. Dec 11, 2020Measure laid before Senate by unanimous consent. (consideration: CR S7450-7451)
  3. Dec 11, 2020Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote. (text of amendment in the nature of a substitute: CR S7450-7451)
  4. Oct 1, 2020Received in the Senate, read twice.
  5. Sep 30, 2020Considered as unfinished business. (consideration: CR H5089-5090)

In the Congressional Record 3

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
SenateDebate and remarks S7450Amendments S7449, S7450Lamar Alexander R-TN (amendment), Mitch McConnell R-KYDec 11, 2020
HouseRecorded votes H5089enactLists H5090Votes recorded by proxy on H.R. 4764, Timely ReAuthorization of Necessary Stem-Cell Programs Lends Access to Needed Therapies (TRANSPLANT) Act—Sep 30, 2020
HouseDebate and remarks H4996–H4998Text printed H4996Christopher H. Smith R-NJ, Frank Pallone, Jr. D-NJ, Greg Walden R-OR, Gus M. Bilirakis R-FLSep 29, 2020

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Committee report

Congressional Budget Office cost estimate

  1. Dec 24, 2020H.R. 4764, TRANSPLANT Act of 2019As ordered reported by the House Committee on Energy and Commerce on September 9, 2020

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Artile 1, Section 8 of the US Constitution

The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 165, October 18, 2019, page H8260.

Printed hearings 1

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
Serial No. 116-123IMPROVING ACCESS TO CARE: LEGISLATION TO REAUTHORIZE KEY PUBLIC HEALTH PROGRAMS176 pagesEnergy and Commerce CommitteeJul 29, 2020

CRS reports 1

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 1

Products on other subjects that cite it, usually among other measures.

Amendments 1

Amendments offered to this bill.

AmendmentDescriptionOffered byStatus
SA 2704In the nature of a substitute.Lamar Alexander R-TNAmendment SA 2704 agreed to in Senate by Unanimous Consent.

Related bills 2

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 3520Stem Cell Therapeutic and Research Reauthorization Act of 2019Related billJun 27, 2019
S 4672TRANSPLANT Act of 2020Related billSep 23, 2020

Titles 11

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.
Short Titles as Passed Senate
TRANSPLANT Act of 2020
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020
Short Title(s) as Introduced
TRANSPLANT Act of 2019
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2019
Short Title(s) as Reported to House
TRANSPLANT Act of 2019
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2019
Short Title(s) as Passed House
TRANSPLANT Act of 2020
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020
Short Title(s) from Engrossed Amendment Senate bill text
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020
TRANSPLANT Act of 2020

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 5

Each version as it was printed, newest first.

  1. Dec 11, 2020Engrossed Amendment Senate
  2. Oct 1, 2020Received in Senate
  3. Sep 30, 2020Engrossed in House
  4. Sep 29, 2020Reported in House
  5. Oct 18, 2019Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.